Provided by Tiger Fintech (Singapore) Pte. Ltd.

Redhill Biopharma

2.86
-0.1500-4.98%
Post-market: 2.70-0.1600-5.59%16:14 EDT
Volume:1.16M
Turnover:3.59M
Market Cap:3.66M
PE:-0.07
High:2.88
Open:2.85
Low:2.60
Close:3.01
Loading ...
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 16, 2024

Correspondence

Form CORRESP - Correspondence
Jun 20, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 08, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 15, 2024

Correspondence

Form CORRESP - Correspondence
Feb 09, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Feb 02, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Oct 26, 2023

Correspondence

Form CORRESP - Correspondence
Aug 10, 2023

Correspondence

Form CORRESP - Correspondence
Jun 29, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 28, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Jan 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 27, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 17, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]